Fri, Jul 1, 2022
A A A
Welcome mteam
RSS

Sovereign Wealth Funds Briefing - Categorized | Investment

Temasek Holdings invests in round in Portola Pharmaceuticals

Posted on 23 November 2011

Singapore’s Temasek Holdings along with other investors invested a round of US$ 89 million in Portola Pharmaceuticals via preferred equity. Portola Pharmaceuticals is a San Francisco biotech company that is working on an anti-clotting drug called betrixaban.
This financing is for pushing the development through its Phase III betrixaban trial. Eight months ago Merck dropped its collaborative efforts with Portola Pharmaceuticals. Temasek Holdings has been an active investor in venture capital investments in the Silicon Valley………………………………………..Full Article: Source


 Article link

This post was written by:

VRS - who has written 19873 posts on Opalesque Sovereign Wealth Funds Briefing.


Contact the author

Comments are closed.

banner
July 2022
M T W T F S S
« Nov    
 123
45678910
11121314151617
18192021222324
25262728293031